Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
Authors
Keywords
T cells, Mouse models, Cytotoxic T cells, Antigen processing and recognition, Virions, B cells, Lytic cycle, Epstein-Barr virus
Journal
PLoS Pathogens
Volume 10, Issue 5, Pages e1004068
Publisher
Public Library of Science (PLoS)
Online
2014-05-23
DOI
10.1371/journal.ppat.1004068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
- (2012) Baochun Zhang et al. CELL
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
- (2011) Riccardo Turrini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune defence against EBV and EBV-associated disease
- (2011) Heather M Long et al. CURRENT OPINION IN IMMUNOLOGY
- Immunotherapy for EBV-associated malignancies
- (2011) Anna Merlo et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
- (2011) H. M. Long et al. JOURNAL OF IMMUNOLOGY
- Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
- (2010) J. J. Melenhorst et al. BLOOD
- Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders
- (2010) K. Jones et al. BLOOD
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Translating Tumor Antigens into Cancer Vaccines
- (2010) Luigi Buonaguro et al. Clinical and Vaccine Immunology
- Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors
- (2010) A. Merlo et al. JOURNAL OF IMMUNOLOGY
- CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells
- (2009) H. M. Long et al. BLOOD
- A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
- (2009) Michael Uhlin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epitope Specificity and Clonality of EBV-Specific CTLs Used to Treat Posttransplant Lymphoproliferative Disease
- (2009) K. A. McAulay et al. JOURNAL OF IMMUNOLOGY
- Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
- (2009) Ulrike Gerdemann et al. MOLECULAR THERAPY
- The History of Tumor Virology
- (2008) R. T. Javier et al. CANCER RESEARCH
- Phenotype and function of human T lymphocyte subsets: Consensus and issues
- (2008) Victor Appay et al. CYTOMETRY PART A
- Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4+ T Cells by Using Virus-Like Particles
- (2008) D. Adhikary et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started